CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
116258-17-4 | (1S,4S)-(+)-2-苄基-2,5-二氮杂双环[2.2.1]庚烷二氢溴酸盐 | (1S,4S)-(+)-2-Benzyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide; 2,5-Diazabicyclo[2.2.1]heptane,2-(phenylmethyl)-, dihydrobromide, (1S)-; 2,5-Diazabicyclo[2.2.1]heptane,2-(phenylmethyl)-, dihydrobromide, (1S,4S)- (9CI); (1S,4S)-2-Benzyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide; (1S,4S)-N-Benzyl-2,5-diazabicyclo[2.2.1]heptane dihydrobromide | C12H18Br2N2 | 详情 | 供应商 | |
119478-55-6 | 甲磺酸达氟沙星; 1-环丙基-6-氟-7-[(1S,4S)-5-甲基-2,5-二氮杂双环[2.2.1]庚烷-2-基]-1,4-二氢-4-氧代喹啉-3 | Danofloxacin mesylate; 1-Cyclopropyl-6-fluoro-7-[(1S,4S)-5-methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monomethanesulfonate | C20H24FN3O6S | 详情 | 供应商 | |
933690-44-9 | 2-氮杂双环[2.2.1]庚烷-2-乙酸 | 2-Azabicyclo[2.2.1]heptane-2-acetic acid | C8H13NO2 | 详情 | 供应商 | |
933735-39-8 | 2-氮杂双环[2.2.1]庚烷-2-丙酸 | 2-Azabicyclo[2.2.1]heptane-2-propanoicacid; 3-(2-Azabicyclo[2.2.1]hept-2-yl)propionicacid | C9H15NO2 | 详情 | 供应商 | |
132339-20-9 | (1S)-2,5-二氮杂双环[2.2.1]庚烷 | 2,5-Diazabicyclo[2.2.1]heptane,(1S,4S)-; 2,5-Diazabicyclo[2.2.1]heptane,(1S)-; (1S,4S)-(+)-2,5-Diazabicyclo[2.2.1]heptane; (1S,4S)-2,5-Diazabicyclo[2.2.1]heptane | C5H10N2 | 详情 | 供应商 | |
31560-06-2 | (1S,4S)-2-氧杂-5-氮杂双环[2.2.1]庚烷盐酸盐; 桥环吗啉盐酸盐 | 2-Oxa-5-azabicyclo[2.2.1]heptane,hydrochloride (1:1), (1S,4S)-; 2-Oxa-5-azabicyclo[2.2.1]heptane,hydrochloride, (1S)-; 2-Oxa-5-azabicyclo[2.2.1]heptane, hydrochloride, (1S,4S)-(8CI,9CI); (1S,4S)-(+)-2-Aza-5-oxabicyclo[2.2.1]heptane hydrochloride; (1S,4S)-2-Oxa-5-azabicyclo[2.2.1]heptane hydrochloride | C5H10ClNO | 详情 | 供应商 | |
1256387-87-7 | (1R,3S,4S)-2-(叔丁氧羰基)- 3-(6-(硼酸频哪醇酯)-1H-苯并[D]咪唑-2-基)-2-氮杂双环[2.2.1]庚烷 | (1R,3S,4S)-tert-butyl 3-(6-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]iMidazol-2-yl)-2; 雷迪帕韦中间体 | 无 | C24H34BN3O4 | 详情 | 供应商 |
1499193-67-7 | (6S)-6-(5-(7-(2-(1R,3S,4S)-2-氮杂双环(2.2.1)庚烷-3-基-1H-苯并咪唑-6-基)-9,9-二氟-9H-芴-2-基)-1H-咪唑-2-基)-5-氮杂螺(2.4)庚烷 | 无 | 详情 | 供应商 | ||
1256387-74-2 | (1R,3S,4S)-3-(6-溴-1H-苯并咪唑-2-基)-2-氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 | 2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-(6-broMo-1H-benziMidazol-2-yl)-, 1,1-diMethylethyl ester,(1R,3S,4S)-; 2-Azabicyclo[2.2.1]heptane-2-carboxylic acid, 3-(6-broMo-1H-benziMidazol-2-yl)-, 1,1-diMethylethyl ester,(1R,3S,4S)-; (1R,3S,4S)-3-(6-Bromo-1H-benzimidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylic acid 1,1-dimethylethyl ester; (1R,3S,4S)-tert-butyl 3-(6-broMo-1H-benzo[d]iMidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate; (1R,3S,4S)-tert-butyl 3-(6-broMo-1Hbenzo[d]iMidazol-2-yl)-2-azabicyclo[2,2,1] heptanes-2-carboxylate; Ledipasvir interMediates; (1R,3S,4S)-3-(6-Bromo-1Hbenzimidazol-2-yl)-2-azabicyclo[2,2,1]heptane--2-carboxylic acid-1,1-dimethylethyleste; Ledipasvir side chain 2; tert-butyl (1R,3S,4S)-3-(6-bromo-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate | 无 | C18H22BrN3O2 | 详情 | 供应商 |